1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Attention Deficit Hyperactivity Disorder Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Stimulants Drugs 1.2.3 Non-stimulants Drugs 1.3 Market by Application 1.3.1 Global Attention Deficit Hyperactivity Disorder Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pediatric 1.3.3 Adolescent 1.3.4 Adults 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Attention Deficit Hyperactivity Disorder Market Perspective (2016-2027) 2.2 Attention Deficit Hyperactivity Disorder Growth Trends by Regions 2.2.1 Attention Deficit Hyperactivity Disorder Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Attention Deficit Hyperactivity Disorder Historic Market Share by Regions (2016-2021) 2.2.3 Attention Deficit Hyperactivity Disorder Forecasted Market Size by Regions (2022-2027) 2.3 Attention Deficit Hyperactivity Disorder Industry Dynamic 2.3.1 Attention Deficit Hyperactivity Disorder Market Trends 2.3.2 Attention Deficit Hyperactivity Disorder Market Drivers 2.3.3 Attention Deficit Hyperactivity Disorder Market Challenges 2.3.4 Attention Deficit Hyperactivity Disorder Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Attention Deficit Hyperactivity Disorder Players by Revenue 3.1.1 Global Top Attention Deficit Hyperactivity Disorder Players by Revenue (2016-2021) 3.1.2 Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Players (2016-2021) 3.2 Global Attention Deficit Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Attention Deficit Hyperactivity Disorder Revenue 3.4 Global Attention Deficit Hyperactivity Disorder Market Concentration Ratio 3.4.1 Global Attention Deficit Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder Revenue in 2020 3.5 Attention Deficit Hyperactivity Disorder Key Players Head office and Area Served 3.6 Key Players Attention Deficit Hyperactivity Disorder Product Solution and Service 3.7 Date of Enter into Attention Deficit Hyperactivity Disorder Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Attention Deficit Hyperactivity Disorder Breakdown Data by Type 4.1 Global Attention Deficit Hyperactivity Disorder Historic Market Size by Type (2016-2021) 4.2 Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Type (2022-2027) 5 Attention Deficit Hyperactivity Disorder Breakdown Data by Application 5.1 Global Attention Deficit Hyperactivity Disorder Historic Market Size by Application (2016-2021) 5.2 Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Attention Deficit Hyperactivity Disorder Market Size (2016-2027) 6.2 North America Attention Deficit Hyperactivity Disorder Market Size by Type 6.2.1 North America Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) 6.2.2 North America Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) 6.2.3 North America Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2027) 6.3 North America Attention Deficit Hyperactivity Disorder Market Size by Application 6.3.1 North America Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) 6.3.2 North America Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) 6.3.3 North America Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2027) 6.4 North America Attention Deficit Hyperactivity Disorder Market Size by Country 6.4.1 North America Attention Deficit Hyperactivity Disorder Market Size by Country (2016-2021) 6.4.2 North America Attention Deficit Hyperactivity Disorder Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Attention Deficit Hyperactivity Disorder Market Size (2016-2027) 7.2 Europe Attention Deficit Hyperactivity Disorder Market Size by Type 7.2.1 Europe Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) 7.2.2 Europe Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) 7.2.3 Europe Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2027) 7.3 Europe Attention Deficit Hyperactivity Disorder Market Size by Application 7.3.1 Europe Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) 7.3.2 Europe Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) 7.3.3 Europe Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2027) 7.4 Europe Attention Deficit Hyperactivity Disorder Market Size by Country 7.4.1 Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2016-2021) 7.4.2 Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size (2016-2027) 8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Type 8.2.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2027) 8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Application 8.3.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2027) 8.4 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Region 8.4.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Attention Deficit Hyperactivity Disorder Market Size (2016-2027) 9.2 Latin America Attention Deficit Hyperactivity Disorder Market Size by Type 9.2.1 Latin America Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) 9.2.2 Latin America Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) 9.2.3 Latin America Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2027) 9.3 Latin America Attention Deficit Hyperactivity Disorder Market Size by Application 9.3.1 Latin America Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) 9.3.2 Latin America Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) 9.3.3 Latin America Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2027) 9.4 Latin America Attention Deficit Hyperactivity Disorder Market Size by Country 9.4.1 Latin America Attention Deficit Hyperactivity Disorder Market Size by Country (2016-2021) 9.4.2 Latin America Attention Deficit Hyperactivity Disorder Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size (2016-2027) 10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Type 10.2.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2027) 10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Application 10.3.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2027) 10.4 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country 10.4.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Company Details 11.1.2 Eli Lilly Business Overview 11.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder Introduction 11.1.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) 11.1.5 Eli Lilly Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Attention Deficit Hyperactivity Disorder Introduction 11.2.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Takeda 11.3.1 Takeda Company Details 11.3.2 Takeda Business Overview 11.3.3 Takeda Attention Deficit Hyperactivity Disorder Introduction 11.3.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) 11.3.5 Takeda Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Details 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Attention Deficit Hyperactivity Disorder Introduction 11.4.4 Pfizer Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) 11.4.5 Pfizer Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Details 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Introduction 11.5.4 GlaxoSmithKline Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) 11.5.5 GlaxoSmithKline Recent Development 11.6 Mallinckrodt 11.6.1 Mallinckrodt Company Details 11.6.2 Mallinckrodt Business Overview 11.6.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Introduction 11.6.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) 11.6.5 Mallinckrodt Recent Development 11.7 Hisamitsu 11.7.1 Hisamitsu Company Details 11.7.2 Hisamitsu Business Overview 11.7.3 Hisamitsu Attention Deficit Hyperactivity Disorder Introduction 11.7.4 Hisamitsu Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) 11.7.5 Hisamitsu Recent Development 11.8 Johnson & Johnson 11.8.1 Johnson & Johnson Company Details 11.8.2 Johnson & Johnson Business Overview 11.8.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Introduction 11.8.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) 11.8.5 Johnson & Johnson Recent Development 11.9 Purdue Parma 11.9.1 Purdue Parma Company Details 11.9.2 Purdue Parma Business Overview 11.9.3 Purdue Parma Attention Deficit Hyperactivity Disorder Introduction 11.9.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) 11.9.5 Purdue Parma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Attention Deficit Hyperactivity Disorder Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Stimulants Drugs Table 3. Key Players of Non-stimulants Drugs Table 4. Global Attention Deficit Hyperactivity Disorder Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Attention Deficit Hyperactivity Disorder Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Attention Deficit Hyperactivity Disorder Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Attention Deficit Hyperactivity Disorder Market Share by Regions (2016-2021) Table 8. Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Attention Deficit Hyperactivity Disorder Market Share by Regions (2022-2027) Table 10. Attention Deficit Hyperactivity Disorder Market Trends Table 11. Attention Deficit Hyperactivity Disorder Market Drivers Table 12. Attention Deficit Hyperactivity Disorder Market Challenges Table 13. Attention Deficit Hyperactivity Disorder Market Restraints Table 14. Global Attention Deficit Hyperactivity Disorder Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Attention Deficit Hyperactivity Disorder Market Share by Players (2016-2021) Table 16. Global Top Attention Deficit Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention Deficit Hyperactivity Disorder as of 2020) Table 17. Ranking of Global Top Attention Deficit Hyperactivity Disorder Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Attention Deficit Hyperactivity Disorder Product Solution and Service Table 21. Date of Enter into Attention Deficit Hyperactivity Disorder Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) (US$ Million) Table 24. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Type (2016-2021) Table 25. Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Attention Deficit Hyperactivity Disorder Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Application (2016-2021) Table 29. Global Attention Deficit Hyperactivity Disorder Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) (US$ Million) Table 32. North America Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) (US$ Million) Table 34. North America Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Attention Deficit Hyperactivity Disorder Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Attention Deficit Hyperactivity Disorder Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Attention Deficit Hyperactivity Disorder Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Attention Deficit Hyperactivity Disorder Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Country (2022-2027) & (US$ Million) Table 61. Eli Lilly Company Details Table 62. Eli Lilly Business Overview Table 63. Eli Lilly Attention Deficit Hyperactivity Disorder Product Table 64. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) & (US$ Million) Table 65. Eli Lilly Recent Development Table 66. Novartis Company Details Table 67. Novartis Business Overview Table 68. Novartis Attention Deficit Hyperactivity Disorder Product Table 69. Novartis Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) & (US$ Million) Table 70. Novartis Recent Development Table 71. Takeda Company Details Table 72. Takeda Business Overview Table 73. Takeda Attention Deficit Hyperactivity Disorder Product Table 74. Takeda Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) & (US$ Million) Table 75. Takeda Recent Development Table 76. Pfizer Company Details Table 77. Pfizer Business Overview Table 78. Pfizer Attention Deficit Hyperactivity Disorder Product Table 79. Pfizer Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) & (US$ Million) Table 80. Pfizer Recent Development Table 81. GlaxoSmithKline Company Details Table 82. GlaxoSmithKline Business Overview Table 83. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Product Table 84. GlaxoSmithKline Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) & (US$ Million) Table 85. GlaxoSmithKline Recent Development Table 86. Mallinckrodt Company Details Table 87. Mallinckrodt Business Overview Table 88. Mallinckrodt Attention Deficit Hyperactivity Disorder Product Table 89. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) & (US$ Million) Table 90. Mallinckrodt Recent Development Table 91. Hisamitsu Company Details Table 92. Hisamitsu Business Overview Table 93. Hisamitsu Attention Deficit Hyperactivity Disorder Product Table 94. Hisamitsu Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) & (US$ Million) Table 95. Hisamitsu Recent Development Table 96. Johnson & Johnson Company Details Table 97. Johnson & Johnson Business Overview Table 98. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) & (US$ Million) Table 99. Johnson & Johnson Recent Development Table 100. Purdue Parma Company Details Table 101. Purdue Parma Business Overview Table 102. Purdue Parma Attention Deficit Hyperactivity Disorder Product Table 103. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder Business (2016-2021) & (US$ Million) Table 104. Purdue Parma Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Attention Deficit Hyperactivity Disorder Market Share by Type: 2020 VS 2027 Figure 2. Stimulants Drugs Features Figure 3. Non-stimulants Drugs Features Figure 4. Global Attention Deficit Hyperactivity Disorder Market Share by Application: 2020 VS 2027 Figure 5. Pediatric Case Studies Figure 6. Adolescent Case Studies Figure 7. Adults Case Studies Figure 8. Attention Deficit Hyperactivity Disorder Report Years Considered Figure 9. Global Attention Deficit Hyperactivity Disorder Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Attention Deficit Hyperactivity Disorder Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Attention Deficit Hyperactivity Disorder Market Share by Regions: 2020 VS 2027 Figure 12. Global Attention Deficit Hyperactivity Disorder Market Share by Regions (2022-2027) Figure 13. Global Attention Deficit Hyperactivity Disorder Market Share by Players in 2020 Figure 14. Global Top Attention Deficit Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention Deficit Hyperactivity Disorder as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder Revenue in 2020 Figure 16. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Type (2016-2021) Figure 17. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Type (2022-2027) Figure 18. North America Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Attention Deficit Hyperactivity Disorder Market Share by Type (2016-2027) Figure 20. North America Attention Deficit Hyperactivity Disorder Market Share by Application (2016-2027) Figure 21. North America Attention Deficit Hyperactivity Disorder Market Share by Country (2016-2027) Figure 22. United States Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Attention Deficit Hyperactivity Disorder Market Share by Type (2016-2027) Figure 26. Europe Attention Deficit Hyperactivity Disorder Market Share by Application (2016-2027) Figure 27. Europe Attention Deficit Hyperactivity Disorder Market Share by Country (2016-2027) Figure 28. Germany Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Share by Type (2016-2027) Figure 36. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Share by Application (2016-2027) Figure 37. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Share by Region (2016-2027) Figure 38. China Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Attention Deficit Hyperactivity Disorder Market Share by Type (2016-2027) Figure 46. Latin America Attention Deficit Hyperactivity Disorder Market Share by Application (2016-2027) Figure 47. Latin America Attention Deficit Hyperactivity Disorder Market Share by Country (2016-2027) Figure 48. Mexico Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Share by Type (2016-2027) Figure 52. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Share by Application (2016-2027) Figure 53. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Share by Country (2016-2027) Figure 54. Turkey Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Attention Deficit Hyperactivity Disorder Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2016-2021) Figure 58. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2016-2021) Figure 59. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2016-2021) Figure 60. Pfizer Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2016-2021) Figure 61. GlaxoSmithKline Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2016-2021) Figure 62. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2016-2021) Figure 63. Hisamitsu Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2016-2021) Figure 64. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2016-2021) Figure 65. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Eli Lilly Novartis Takeda Pfizer GlaxoSmithKline Mallinckrodt Hisamitsu Johnson & Johnson Purdue Parma